Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Disease Progression and PTS[original query] |
---|
A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations. Lung cancer (Amsterdam, Netherlands) 2011 Jan 71 (1): 65-9. Kim Dong-Wan, Lee Se-Hoon, Lee Jong Seok, Lee Myung Ah, Kang Jin Hyoung, Kim Si Young, Shin Sang Won, Kim Hoon-Kyo, Heo Dae Se |
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels. Annals of hematology 2022 Oct . Lewandowski Krzysztof, Kandu?a Zuzanna, Gniot Micha?, Paczkowska Edyta, Nawrocka Paulina Maria, Wojtaszewska Marzena, Janowski Micha?, Mariak Magdalena, Handschuh Luiza, Kozlowski Pio |
JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source: